# Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation

> **NCT02549066** · NA · COMPLETED · sponsor: **Sahlgrenska University Hospital** · enrollment: 18 (actual)

## Conditions studied

- Complication of Extracorporeal Circulation
- Kidney Circulation Disorder
- Renal Function Disorder

## Interventions

- **PROCEDURE:** Increased cardiopulmonary bypass flow
- **DRUG:** Milrinone

## Key facts

- **NCT ID:** NCT02549066
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549066, "Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02549066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*